SG Americas Securities’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.95M | Buy |
34,624
+10,083
| +41% | +$724K | ﹤0.01% | 1316 |
|
|
2026
Q1 | $1.62M | Sell |
24,541
-7,655
| -24% | -$487K | ﹤0.01% | 1496 |
|
|
2025
Q4 | $2.05M | Sell |
32,196
-19,201
| -37% | -$1.19M | ﹤0.01% | 1513 |
|
|
2025
Q3 | $2.83M | Buy |
51,397
+43,349
| +539% | +$1.79M | 0.01% | 774 |
|
|
2025
Q2 | $266K | Buy |
8,048
+1,317
| +20% | +$45.8K | ﹤0.01% | 2092 |
|
|
2025
Q1 | $271K | Buy |
+6,731
| New | +$309K | ﹤0.01% | 2294 |
|
|
2024
Q4 | – | Sell |
-22,203
| Closed | -$1.17M | – | 3235 |
|
|
2024
Q3 | $1.17M | Sell |
22,203
-115,939
| -84% | -$6.46M | ﹤0.01% | 963 |
|
|
2024
Q2 | $7.49M | Buy |
138,142
+129,057
| +1,421% | +$7.79M | 0.04% | 403 |
|
|
2024
Q1 | $637K | Sell |
9,085
-14,073
| -61% | -$1.09M | ﹤0.01% | 1316 |
|
|
2023
Q4 | $1.93M | Sell |
23,158
-1,221
| -5% | -$44.2K | 0.02% | 696 |
|
|
2023
Q3 | $718K | Buy |
+24,379
| New | +$812K | 0.01% | 1521 |
|
|
2023
Q2 | – | Sell |
-46,654
| Closed | -$1.64M | – | 2470 |
|
|
2023
Q1 | $1.64M | Buy |
46,654
+43,156
| +1,234% | +$1.76M | 0.02% | 794 |
|
|
2022
Q4 | $160K | Sell |
3,498
-2,093
| -37% | -$90.1K | ﹤0.01% | 2373 |
|
|
2022
Q3 | $271K | Sell |
5,591
-3,631
| -39% | -$175K | ﹤0.01% | 2078 |
|
|
2022
Q2 | $362K | Sell |
9,222
-40,422
| -81% | -$1.63M | ﹤0.01% | 2235 |
|
|
2022
Q1 | $1.83M | Sell |
49,644
-14,157
| -22% | -$503K | 0.01% | 987 |
|
|
2021
Q4 | $2.91M | Sell |
63,801
-3,128
| -5% | -$121K | 0.02% | 806 |
|
|
2021
Q3 | $2.39M | Buy |
66,929
+50,152
| +299% | +$1.48M | 0.01% | 1106 |
|
|
2021
Q2 | $332K | Sell |
16,777
-3,574
| -18% | -$83.9K | ﹤0.01% | 2121 |
|
|
2021
Q1 | $473K | Sell |
20,351
-10,706
| -34% | -$229K | ﹤0.01% | 2056 |
|
|
2020
Q4 | $645K | Sell |
31,057
-2,059
| -6% | -$37.6K | ﹤0.01% | 1799 |
|
|
2020
Q3 | $717K | Buy |
33,116
+16,989
| +105% | +$397K | ﹤0.01% | 1402 |
|
|
2020
Q2 | $380K | Sell |
16,127
-31,637
| -66% | -$593K | ﹤0.01% | 2337 |
|
|
2020
Q1 | $563K | Buy |
+47,764
| New | +$609K | 0.01% | 1757 |
|
|
2019
Q4 | – | Sell |
-14,708
| Closed | -$167K | – | 3308 |
|
|
2019
Q3 | $167K | Buy |
+14,708
| New | +$185K | ﹤0.01% | 2441 |
|
|
2019
Q2 | – | Sell |
-18,642
| Closed | -$151K | – | 3147 |
|
|
2019
Q1 | $151K | Buy |
+18,642
| New | +$137K | ﹤0.01% | 2769 |
|
|
2017
Q4 | – | Sell |
-9,360
| Closed | -$136K | – | 3266 |
|
|
2017
Q3 | $136K | Sell |
9,360
-4,946
| -35% | -$67.6K | ﹤0.01% | 2940 |
|
|
2017
Q2 | $173K | Buy |
14,306
+6,052
| +73% | +$84.1K | ﹤0.01% | 2540 |
|
|
2017
Q1 | $106K | Sell |
8,254
-7,297
| -47% | -$85.3K | ﹤0.01% | 2954 |
|
|
2016
Q4 | $189K | Buy |
+15,551
| New | +$165K | ﹤0.01% | 2398 |
|
Other funds holding CYTK
ACA
SG Americas Securities's CYTK Position: Q2 2026 in Review
SG Americas Securities increased its Cytokinetics (CYTK) stake by 41% in Q2 2026, buying an estimated $724K and bringing the position to 34,624 shares worth $2.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1316.
SG Americas Securities first reported a position in CYTK in Q4 2016 and has held it in 30 quarters since. The position peaked at $7.49M in Q2 2024. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.
- SG Americas Securities held 34,624 shares of Cytokinetics worth $2.95M as of Q2 2026.
- SG Americas Securities bought 10,083 Cytokinetics shares in Q2 2026, an estimated $724K.
- Cytokinetics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1316 holding.
- SG Americas Securities first reported a position in Cytokinetics in Q4 2016 and has held it in 30 quarters since.
- SG Americas Securities's Cytokinetics position peaked at $7.49M in Q2 2024.
- 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.